Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BID | P55957 | 7/20 | 1.00 |
| ▸ | MCL1 | Q07820 | 7/20 | 1.00 |
| ▸ | BCL2L1 | Q07817 | 6/20 | 1.00 |
| ▸ | BAK1 | Q16611 | 6/20 | 1.00 |
| ▸ | KAT8 | Q9H7Z6 | 3/20 | 1.00 |
| ▸ | PPARA | Q07869 | 3/20 | 1.00 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 1.00 |
| ▸ | EP300 | Q09472 | 2/20 | 1.00 |
| ▸ | KAT5 | Q92993 | 2/20 | 1.00 |
| ▸ | PPARG | P37231 | 2/20 | 1.00 |
| ▸ | KAT2A | Q92830 | 1/20 | 1.00 |
| ▸ | KAT2B | Q92831 | 1/20 | 1.00 |
| ▸ | F7 | P08709 | 3/20 | 0.84 |
| ▸ | F3 | P13726 | 3/20 | 0.84 |
| ▸ | MMP2 | P08253 | 2/20 | 0.84 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.84 |
| ▸ | MAPT | P10636 | 1/20 | 0.84 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.84 |
| ▸ | ECE1 | P42892 | 1/20 | 0.84 |
| ▸ | SGMS1 | Q86VZ5 | 1/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2558603 | 1.00 | BID (1.00) | BIDMCL1BCL2L1BAK1KAT8 | |
| Ginkgolic Acid 13:0 SCHEMBL20298323 | 1.00 | BID (1.00) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5378937 | 1.00 | BID (1.00) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL10877233 | 1.00 | BID (1.00) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5379149 | 1.00 | BID (1.00) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL4248799 | 1.00 | BID (1.00) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5378991 | 1.00 | BID (1.00) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL16237264 | 1.00 | BID (1.00) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL2126888 | 1.00 | BID (1.00) | BIDMCL1BCL2L1BAK1KAT8 | |
| Anacardic Acid SCHEMBL29408556 | 1.00 | BID (1.00) | BIDMCL1BCL2L1BAK1KAT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250216402-A1 | BIOMARKERS FOR SEVERITY OF ISCHEMIC STROKE AND USE THEREOF | ZHEJIANG CHINESE MEDICAL UNIVERSITY (CN) | 2025-07-03 | — | — | US | claimed |
| CN-120005443-A | Low-VOC-emission special printing ink for children's painting and preparation method and application thereof | 浙江华旭实业有限公司 | 2025-05-16 | — | — | CN | claimed |
| WO-2025030135-A2 | METHODS FOR TREATING AND AMELIORATING ANGINA, MYOCARDIAL INFARCTION, REPERFUSION INJURY, HEART ARRHYTHMIAS AND CONGESTIVE HEART FAILURE (CHF) | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-02-06 | — | — | WO | claimed |
| CN-117929747-A | Biomarker for severity of ischemic cerebral apoplexy and application thereof | 浙江中医药大学 | 2024-04-26 | — | — | CN | claimed |
| US-20170095436-A1 | METHODS FOR TREATING MENDELIAN DISORDERS OF THE EPIGENETIC MACHINERY | THE JOHNS HOPKINS UNIVERSITY (US) | 2017-04-06 | — | — | US | claimed |
| WO-2015184260-A2 | METHODS FOR TREATING MENDELIAN DISORDERS OF THE EPIGENETIC MACHINERY | THE JOHNS HOPKINS UNIVERSITY (US) | 2015-12-03 | — | — | WO | claimed |
| US-7196214-B2 | Process for arylamine production | XEROX CORPORATION (US) | 2007-03-27 | — | — | US | claimed |
| US-20060111582-A1 | Process for arylamine production | XEROX CORPORATION (US) | 2006-05-25 | — | — | US | claimed |
| US-5240962-A | Antiobesity and fat-reducing agents | TAKASAGO INSTITUTE FOR INTERDISCIPLINARY SCIENCE, INC. (US) | 1993-08-31 | — | — | US | claimed |
| JP-5170645-A | — | — | None | — | — | JP | disclosed |
| JP-2255609-A | — | — | None | — | — | JP | disclosed |
| CN-122075461-A | Application of anacardic acid in preparation of core protease I7L activity inhibitor and anti-orthopoxvirus infection medicine | — | 2026-05-26 | — | — | CN | disclosed |
| US-12552959-B2 | Aqueous coating composition for corrosion protection | ALLNEX AUSTRIA GMBH (AT) | 2026-02-17 | — | — | US | disclosed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | disclosed |
| WO-2003062201-A1 | 1,4-DIHYDROPYRIDINE AND PYRIDINE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS | VITTAL MALLYA SCIENTIFIC RESEARCH FOUNDATION (IN) | 2003-07-31 | — | — | WO | disclosed |
| US-6117431-A | Method for obtaining an extract from ginkgo biloba leaves | PHARMLINE INC. (US) | 2000-09-12 | — | — | US | disclosed |
| US-5240962-A | Antiobesity and fat-reducing agents | TAKASAGO INSTITUTE FOR INTERDISCIPLINARY SCIENCE, INC. (US) | 1993-08-31 | — | — | US | disclosed |
| JP-H05170645-A | INHIBITOR OF CARBOHYDRATE-HYDROLYZING ENZYME IN INTESTINE | TAKASAGO INST FOR INTERDISCIPLINARY SCI INC | 1993-07-09 | — | — | JP | disclosed |
| US-5202355-A | Administering for diabetic neuropathy | TAKASAGO INSTITUTE FOR INTERDISCIPLINARY SCIENCE INC. (US) | 1993-04-13 | — | — | US | disclosed |
| JP-H02255609-A | ANTIMICROBIAL AGENT COMPOSITION FOR ORAL CAVITY | SUNSTAR INC | 1990-10-16 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552959-B2 | Aqueous coating composition for corrosion protection | ADH1A, ADH1C, TET1 | BID 4218/4885MCL1 1367/4885BCL2L1 4641/4885 |
| US-20060111582-A1 | Process for arylamine production | AOC2, UFM1, TYR | BID 3728/4885MCL1 3212/4885BCL2L1 4785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.